Principal Consultant
Sunita Teekasingh is a highly accomplished Regulatory Affairs Strategy Director with over 15 years of comprehensive experience in leading global regulatory strategy for medical devices and IVDs. She has a proven expertise in navigating complex product portfolios (over 9,000 SKUs across 130+ geographies) and ensuring compliance in major markets including the U.S., EU, Canada, and Asia-Pacific. Suni...
Experience: 15+ years
Submissions: 58 510(k)
Sunita Teekasingh provides regulatory consulting services to clients in:
Holds an MSc and a BSN, complemented by RN and CCRN certifications, demonstrating a strong foundation in nursing and advanced studies. This academic and clinical background provides a unique perspective on patient care and medical device efficacy, directly enhancing regulatory expertise in medical and IVD product development and compliance. The combination of advanced degrees and specialized certifications signifies a deep commitment to healthcare and regulatory science.
A highly accomplished Regulatory Affairs Strategy Director with over 15 years of experience leading global regulatory strategies for medical devices and IVDs. Proven success in complex product portfolios, achieving over 58 FDA clearances with significantly faster-than-industry-average review times. Expertise spans strategic oversight for 510(k) submissions, IVDR compliance, and high-stakes crisis management, including recovering denied PMAs and resolving DOJ investigations. Adept at liaising with global health authorities and managing project teams to ensure compliance across major markets and protect company revenue.
Sunita Teekasingh is a highly accomplished Regulatory Affairs Strategy Director with over 15 years of comprehensive experience in leading global regulatory strategy for medical devices and IVDs. She has a proven expertise in navigating complex product portfolios (over 9,000 SKUs across 130+ geograph...
With 15 years of experience specializing in medtech and IVD compliance, this consultant is uniquely valuable for their regulatory expertise depth in navigating complex product portfolios across 130+ geographies, including the U.S., EU, Canada, and Asia-Pacific. Their exceptional ability to develop and implement high-level strategies for 510(k) submissions, IVDR compliance, and high-stakes crisis management has led to 58 FDA clearances with significantly faster-than-industry-average review times. Their expertise spans strategic oversight for 510(k) submissions, IVDR compliance, and high-stakes crisis management, including recovering denied PMAs and resolving DOJ investigations. Additionally, they possess extensive knowledge of critical regulatory standards and demonstrate proficiency in developing robust quality processes, risk management frameworks, and compliance training programs. This combination of expertise, experience, and technical skills makes them an invaluable asset for medtech companies seeking regulatory excellence.
This analysis is generated by Cruxi AI using public information and may not capture the full scope of the consultant's experience.
Share a brief overview of your device and timeline. Cruxi will forward your request to Sunita Teekasingh and help structure next steps.
Contact Now